JCRB1506 POLK KO-comp
Cell information
Important Notice(s)Cell type：genetically-modified cells (View Pricing Information)
| JCRB No. | JCRB1506 | Cell Name | POLK KO-comp |
|---|---|---|---|
| Profile | Human cell line derived from B cell leukemia. (MSH+, POLK KO->steable transfectant of pEF6-Polk, TK+/-) | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 19-year-old |
| Identity | available | Tissue for Primary Cancer | |
| Case history | acute lymphoblastic leukemia (ALL) | Metastasis | |
| Tissue Metastasized | Genetics | MSH+, POLK KO->complemented, TK+/- | |
| Life Span | infinite | Crisis PDL | |
| Morphology | lymphocyte-like | Character | |
| Classify | transformed | Established by | Kanemaru, Y. |
| Registered by | Nohmi, T. | Regulation for Distribution | Required depositor's approval. |
| Comment | Year | 2012 | |
| Medium | RPMI 1640 + 10% heat-inactivate FBS | Methods for Passages | dilution |
| Cell Number on Passage | twice/week, split ratio = 1:10 | Race | |
| CO2 Conc. | 5% | Tissue Sampling | peripheral blood |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:26031400 | Catalytic and non-catalytic roles of DNA polymerase κ in the protection of human cells against genotoxic stresses. Kanemaru Y,Suzuki T,Niimi N,Grúz P,Matsumoto K,Adachi N,Honma M,Nohmi T Environ Mol Mutagen. 2015 Oct;56(8):650-62 |
| Images |
|---|
      |
LOT Information
| Cell No. | JCRB1506 | Cell Name | POLK KO-comp |
|---|---|---|---|
| LOT No. | 12072012 | Lot Specification | distribution |
| Medium | RPMI1640 medium(GIBCO) with 10% heat inactivated fetal bovine serum(SIGMA027K03911) | Temperature | 37 C |
| Cell Density at Seeding | 1.00-2.83x10^5 cells/ml | Methods for Passages | Dilution (twice a week,split ratio=1:10) |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 5.86x10^6 |
| Viability at cell freezing (%) | 98.7 | Antibiotics Used | free |
| Passage Number | p3* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11,12 D13S317:8,13 D7S820:8,12 D16S539:10,11 VWA:15,16 TH01:8,9 AM:X,Y TPOX:8,10 CSF1PO:14 |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
| Viability immediately after thawing (%) | Additional information |
| Images |
|---|
|
|